Boston Scientific - ACCOLADE and ESSENTIO
by Boston Scientific

Follow Us

ACCOLADE and ESSENTIO are Boston Scientific’s most advanced Pacemakers offering the assurance of Automatic Daily Monitoring to improve patient compliance, actionable data to enable earlier intervention, and the longest projected longevity in the industry.

ACCOLADE and ESSENTIO feature Automatic Daily Monitoring with the LATITUDE NXT Patient Management System to improve clinic efficiency and provide a higher level of care for user's device patients. With LATITUDE NXT, these systems provide automatic and customizable alerts and device interrogation with no interaction from the patient enabling earlier arrhythmia detection and improved patient compliance.

Ask a New Question


  • The new Atrial Arrhythmia Report is now available with ACCOLADE Pacemakers, providing a comprehensive view of patient’s AT/AF status and information for assessing AF treatment efficacy
  • ACCOLADE Pacemakers carry forward the HF PERSPECTIV System, a comprehensive suite of diagnostics that can provide insight into HF disease progression including Respiratory Rate Trend (RRT) which allows users to measure and track patient’s respiration; Heart Rate Variability (HRV) footprint; SDANN; Autonomic Balance Monitor and heart rate trend showing long-term maximum, minimum and average heart rate
  • The new Post-Operative System Test (POST) feature, providing a fully automatic system evaluation to check lead impedances, intrinsic amplitudes and capture thresholds prior to discharge 
  • The new Snapshot Capability for real-time review of EGM/ECG data and pacing threshold test results 
  • The EasyView Header with new port labels to aid with quick and easy identification of the appropriate port and verification of full lead insertion


Boston Scientific - ACCOLADE L300

Boston Scientific - ACCOLADE L301

Boston Scientific - ACCOLADE L321

Boston Scientific - ESSENTIO L100

Boston Scientific - ESSENTIO L101

Boston Scientific - ESSENTIO L121

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree